QPharma

QParma is a Global speciality Contract Development and Manufacturing Organisation (CDMO) with expertise in polymer and sterile injectable based and/or high potent pharmaceutical products and services.

Commercial products span various high potent products, including oral solid dosage, polymer based vaginal rings, inserts and implants and sterile product formulations. Development services cover the full range of pharmaceutical development activities from idea through feasibility, technical trials, pharmaceutical and analytical development, clinical trials, regulatory affairs and market access, and finally commercialization.

Overall, QParma provides a unique value proposition. Speciality niche product formulations demands a variety of competence areas, and very few CDMO will offer these services. Globally, there are very few competitors.

QParma has development and manufacturing sites in Malmö, Sweden and also in Connecticut, USA.

Fredrik Hultenius
Chief Executive Officer
View Profile
Visit QPharma